Skip to main content
. 2021 Jun 24;13(7):951. doi: 10.3390/pharmaceutics13070951

Table 4.

Concentrations of IL-6, IL-1 and TNF-α obtained for control cells and formulations F-A0 and F-A0E (non-loaded MPs) before and after exposing cell macrophages to LPS (lipopolysaccharide).

Formulation LPS (μg) Concentration (pg/mL)
IL-1 IL-6 TNF-α
Control - 22.6 ± 0.13 25.3 ± 0.03 220.6 ± 0.3
0.7 43.27 ± 2.79 47.70 ± 10.46 526.08 ± 0.088
F-A0 - 28.9 ± 0.23 30.2 ± 0.03 308.9 ± 0.45
0.7 36.38 ± 1.63 40.35 ± 1.63 653.38 ± 3.5
F-A0E - 30.2 ± 0.02 29.83 ± 0.02 300.2 ± 0.23
0.7 44.20 ± 4.24 49.23 ± 11.06 600.4 ± 14.13